SB-656933-AAA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SB-656933-AAA, covering 2017-08-03 to 2017-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone [Phase 1]